PD-1 Inhibitor
PD-1 Inhibitor market is segmented by region (country), players, by Type and by Application. Play ... Read More
Global and United States Apatinib Market Report & Forecast 2024-2031
1 Study Coverage
1.1 Apatinib Product Introduction
1.2 Global Apatinib Outlook 2017 VS 2022 VS 2028
1.2.1 Global Apatinib Sales in US$ Million for the Year 2017-2028
1.2.2 Global Apatinib Sales in Volume for the Year 2017-2028
1.3 United States Apatinib Outlook 2017 VS 2022 VS 2028
1.3.1 United States Apatinib Sales in US$ Million for the Year 2017-2028
1.3.2 United States Apatinib Sales in Volume for the Year 2017-2028
1.4 Apatinib Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Apatinib in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Apatinib Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Apatinib Market Dynamics
1.5.1 Apatinib Industry Trends
1.5.2 Apatinib Market Drivers
1.5.3 Apatinib Market Challenges
1.5.4 Apatinib Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Apatinib Market Segment by Type
2.1.1 0.25g/Pcs
2.1.2 0.425g/Pcs
2.1.3 0.375g/Pcs
2.2 Global Apatinib Market Size by Type
2.2.1 Global Apatinib Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Apatinib Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Apatinib Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Apatinib Market Size by Type
2.3.1 United States Apatinib Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Apatinib Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Apatinib Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Apatinib Market Segment by Application
3.1.1 Metastatic Gastric Carcinoma
3.1.2 Metastatic Breast Cancer
3.1.3 Advanced Hepatocellular Carcinoma
3.1.4 Other
3.2 Global Apatinib Market Size by Application
3.2.1 Global Apatinib Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Apatinib Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Apatinib Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Apatinib Market Size by Application
3.3.1 United States Apatinib Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Apatinib Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Apatinib Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Apatinib Competitor Landscape by Company
4.1 Global Apatinib Market Size by Company
4.1.1 Top Global Apatinib Manufacturers Ranked by Revenue (2021)
4.1.2 Global Apatinib Revenue by Manufacturer (2017-2022)
4.1.3 Global Apatinib Sales by Manufacturer (2017-2022)
4.1.4 Global Apatinib Price by Manufacturer (2017-2022)
4.2 Global Apatinib Concentration Ratio (CR)
4.2.1 Apatinib Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Apatinib in 2021
4.2.3 Global Apatinib Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Apatinib Manufacturing Base Distribution, Product Type
4.3.1 Global Apatinib Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Apatinib Product Type
4.3.3 Date of International Manufacturers Enter into Apatinib Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Apatinib Market Size by Company
4.5.1 Top Apatinib Players in United States, Ranked by Revenue (2021)
4.5.2 United States Apatinib Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Apatinib Sales by Players (2020, 2021 & 2022)
5 Global Apatinib Market Size by Region
5.1 Global Apatinib Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Apatinib Market Size in Volume by Region (2017-2028)
5.2.1 Global Apatinib Sales in Volume by Region: 2017-2022
5.2.2 Global Apatinib Sales in Volume Forecast by Region (2023-2028)
5.3 Global Apatinib Market Size in Value by Region (2017-2028)
5.3.1 Global Apatinib Sales in Value by Region: 2017-2022
5.3.2 Global Apatinib Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Apatinib Market Size YoY Growth 2017-2028
6.1.2 North America Apatinib Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Apatinib Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Apatinib Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Apatinib Market Size YoY Growth 2017-2028
6.3.2 Europe Apatinib Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Apatinib Market Size YoY Growth 2017-2028
6.4.2 Latin America Apatinib Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Apatinib Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Apatinib Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Advenchen Laboratories
7.1.1 Advenchen Laboratories Corporation Information
7.1.2 Advenchen Laboratories Description and Business Overview
7.1.3 Advenchen Laboratories Apatinib Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Advenchen Laboratories Apatinib Products Offered
7.1.5 Advenchen Laboratories Recent Development
7.2 Jiangsu Hengrui Medicine
7.2.1 Jiangsu Hengrui Medicine Corporation Information
7.2.2 Jiangsu Hengrui Medicine Description and Business Overview
7.2.3 Jiangsu Hengrui Medicine Apatinib Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Jiangsu Hengrui Medicine Apatinib Products Offered
7.2.5 Jiangsu Hengrui Medicine Recent Development
7.3 LSK BioPartners
7.3.1 LSK BioPartners Corporation Information
7.3.2 LSK BioPartners Description and Business Overview
7.3.3 LSK BioPartners Apatinib Sales, Revenue and Gross Margin (2017-2022)
7.3.4 LSK BioPartners Apatinib Products Offered
7.3.5 LSK BioPartners Recent Development
7.4 Bukwang Pharmaceutical Company
7.4.1 Bukwang Pharmaceutical Company Corporation Information
7.4.2 Bukwang Pharmaceutical Company Description and Business Overview
7.4.3 Bukwang Pharmaceutical Company Apatinib Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Bukwang Pharmaceutical Company Apatinib Products Offered
7.4.5 Bukwang Pharmaceutical Company Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Apatinib Industry Chain Analysis
8.2 Apatinib Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Apatinib Distributors
8.3 Apatinib Production Mode & Process
8.4 Apatinib Sales and Marketing
8.4.1 Apatinib Sales Channels
8.4.2 Apatinib Distributors
8.5 Apatinib Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Apatinib CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. Apatinib Market Trends
Table 3. Apatinib Market Drivers
Table 4. Apatinib Market Challenges
Table 5. Apatinib Market Restraints
Table 6. Global Apatinib Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Apatinib Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Apatinib Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Apatinib Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Apatinib Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global Apatinib Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global Apatinib Revenue Share by Manufacturer, 2017-2022
Table 13. Global Apatinib Sales by Manufacturer, (K Pcs), 2017-2022
Table 14. Global Apatinib Sales Share by Manufacturer, 2017-2022
Table 15. Global Apatinib Price by Manufacturer (2017-2022) & (USD/Pcs)
Table 16. Global Apatinib Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Apatinib by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Apatinib as of 2021)
Table 18. Top Players of Apatinib in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers Apatinib Product Type
Table 20. Date of International Manufacturers Enter into Apatinib Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top Apatinib Players in United States Market, Ranking by Revenue (2021)
Table 23. United States Apatinib Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States Apatinib Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States Apatinib Sales by Players, (K Pcs), 2020, 2021 & 2022
Table 26. United States Apatinib Sales Share by Players, 2020, 2021 & 2022
Table 27. Global Apatinib Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global Apatinib Sales in Volume by Region (2017-2022) & (K Pcs)
Table 29. Global Apatinib Sales in Volume Forecast by Region (2023-2028) & (K Pcs)
Table 30. Global Apatinib Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global Apatinib Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America Apatinib Sales in Volume by Country (2017-2028) & (K Pcs)
Table 33. North America Apatinib Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific Apatinib Sales in Volume by Region (2017-2028) & (K Pcs)
Table 35. Asia Pacific Apatinib Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe Apatinib Sales in Volume by Country (2017-2028) & (K Pcs)
Table 37. Europe Apatinib Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America Apatinib Sales in Volume by Country (2017-2028) & (K Pcs)
Table 39. Latin Americaa Apatinib Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa Apatinib Sales in Volume by Country (2017-2028) & (K Pcs)
Table 41. Middle East and Africa Apatinib Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. Advenchen Laboratories Corporation Information
Table 43. Advenchen Laboratories Description and Business Overview
Table 44. Advenchen Laboratories Apatinib Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 45. Advenchen Laboratories Apatinib Product
Table 46. Advenchen Laboratories Recent Development
Table 47. Jiangsu Hengrui Medicine Corporation Information
Table 48. Jiangsu Hengrui Medicine Description and Business Overview
Table 49. Jiangsu Hengrui Medicine Apatinib Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 50. Jiangsu Hengrui Medicine Product
Table 51. Jiangsu Hengrui Medicine Recent Development
Table 52. LSK BioPartners Corporation Information
Table 53. LSK BioPartners Description and Business Overview
Table 54. LSK BioPartners Apatinib Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 55. LSK BioPartners Product
Table 56. LSK BioPartners Recent Development
Table 57. Bukwang Pharmaceutical Company Corporation Information
Table 58. Bukwang Pharmaceutical Company Description and Business Overview
Table 59. Bukwang Pharmaceutical Company Apatinib Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 60. Bukwang Pharmaceutical Company Product
Table 61. Bukwang Pharmaceutical Company Recent Development
Table 62. Key Raw Materials Lists
Table 63. Raw Materials Key Suppliers Lists
Table 64. Apatinib Customers List
Table 65. Apatinib Distributors List
Table 66. Research Programs/Design for This Report
Table 67. Key Data Information from Secondary Sources
Table 68. Key Data Information from Primary Sources
List of Figures
Figure 1. Apatinib Product Picture
Figure 2. Global Apatinib Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Apatinib Market Size 2017-2028 (US$ Million)
Figure 4. Global Apatinib Sales 2017-2028 (K Pcs)
Figure 5. United States Apatinib Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States Apatinib Market Size 2017-2028 (US$ Million)
Figure 7. United States Apatinib Sales 2017-2028 (K Pcs)
Figure 8. United States Apatinib Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States Apatinib Market Share in Global, in Volume (K Pcs) 2017-2028
Figure 10. Apatinib Report Years Considered
Figure 11. Product Picture of 0.25g/Pcs
Figure 12. Product Picture of 0.425g/Pcs
Figure 13. Product Picture of 0.375g/Pcs
Figure 14. Global Apatinib Market Share by Type in 2022 & 2028
Figure 15. Global Apatinib Sales in Value by Type (2017-2028) & (US$ Million)
Figure 16. Global Apatinib Sales Market Share in Value by Type (2017-2028)
Figure 17. Global Apatinib Sales by Type (2017-2028) & (K Pcs)
Figure 18. Global Apatinib Sales Market Share in Volume by Type (2017-2028)
Figure 19. Global Apatinib Price by Type (2017-2028) & (USD/Pcs)
Figure 20. United States Apatinib Market Share by Type in 2022 & 2028
Figure 21. United States Apatinib Sales in Value by Type (2017-2028) & (US$ Million)
Figure 22. United States Apatinib Sales Market Share in Value by Type (2017-2028)
Figure 23. United States Apatinib Sales by Type (2017-2028) & (K Pcs)
Figure 24. United States Apatinib Sales Market Share in Volume by Type (2017-2028)
Figure 25. United States Apatinib Price by Type (2017-2028) & (USD/Pcs)
Figure 26. Product Picture of Metastatic Gastric Carcinoma
Figure 27. Product Picture of Metastatic Breast Cancer
Figure 28. Product Picture of Advanced Hepatocellular Carcinoma
Figure 29. Product Picture of Other
Figure 30. Global Apatinib Market Share by Application in 2022 & 2028
Figure 31. Global Apatinib Sales in Value by Application (2017-2028) & (US$ Million)
Figure 32. Global Apatinib Sales Market Share in Value by Application (2017-2028)
Figure 33. Global Apatinib Sales by Application (2017-2028) & (K Pcs)
Figure 34. Global Apatinib Sales Market Share in Volume by Application (2017-2028)
Figure 35. Global Apatinib Price by Application (2017-2028) & (USD/Pcs)
Figure 36. United States Apatinib Market Share by Application in 2022 & 2028
Figure 37. United States Apatinib Sales in Value by Application (2017-2028) & (US$ Million)
Figure 38. United States Apatinib Sales Market Share in Value by Application (2017-2028)
Figure 39. United States Apatinib Sales by Application (2017-2028) & (K Pcs)
Figure 40. United States Apatinib Sales Market Share in Volume by Application (2017-2028)
Figure 41. United States Apatinib Price by Application (2017-2028) & (USD/Pcs)
Figure 42. North America Apatinib Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 43. North America Apatinib Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 44. U.S. Apatinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 45. Canada Apatinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 46. Europe Apatinib Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 47. Europe Apatinib Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 48. Germany Apatinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 49. France Apatinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 50. U.K. Apatinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 51. Italy Apatinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 52. Russia Apatinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 53. Asia-Pacific Apatinib Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 54. Asia-Pacific Apatinib Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 55. China Apatinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 56. Japan Apatinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 57. South Korea Apatinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 58. India Apatinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 59. Australia Apatinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 60. Taiwan Apatinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 61. Indonesia Apatinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 62. Thailand Apatinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 63. Malaysia Apatinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 64. Philippines Apatinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 65. Latin America Apatinib Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 66. Latin America Apatinib Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 67. Mexico Apatinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 68. Brazil Apatinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 69. Argentina Apatinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 70. Middle East & Africa Apatinib Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 71. Middle East & Africa Apatinib Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 72. Turkey Apatinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 73. Saudi Arabia Apatinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 74. U.A.E Apatinib Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 75. Apatinib Value Chain
Figure 76. Apatinib Production Process
Figure 77. Channels of Distribution
Figure 78. Distributors Profiles
Figure 79. Bottom-up and Top-down Approaches for This Report
Figure 80. Data Triangulation
Figure 81. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Advenchen Laboratories Jiangsu Hengrui Medicine LSK BioPartners Bukwang Pharmaceutical Company